The effect of propolis extract in experimental chemical corneal injury

Ophthalmic Research

Volumn 32, Issue 1, 2000, Pages 13-18

  Öztürk, Faruk ^a,b   Kurt, Emin ^a   Çerçi, Mehmet ^a   Emiroǧlu, Levent ^a   Inan, Übeyt ^a   Türker, Mehmet ^a   Ilker, Sami ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b Merkez Efendi Mh Senol Sk Y   (Turkey)

Author keywords

Alkali burn; Anti inflammatory therapy; Corneal inflammation; Corticosteroids; Propolis

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; DEXAMETHASONE; KETAMINE; OXYBUPROCAINE; P 8904; PENTOBARBITAL; PHOSPHATE; PROPOLIS; SODIUM HYDROXIDE; TOBRAMYCIN; UNCLASSIFIED DRUG; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CAUSTIC BURN; CELL INFILTRATION; CONTROLLED STUDY; CORNEA EDEMA; CORNEA INJURY; HISTOLOGY; HYPEREMIA; KERATITIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; WOUND HEALING;

EID: 0342545470     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055581     Document Type: Article

References (30)

1. Wagoner MD: Chemical injuries of the eye. Current concepts in pathophysiology and therapy. Surv Ophthalmol 1997;41:275-313.
2. Pfister RR, Haddox JL, Yulille-Barr D: The combined effect of citrate/ascorbate treatment in alkali-injured rabbit eyes. Cornea 1991;10: 100-104.
3. Laria C, Alio JL, Ruiz-Moreno JM: Combined non-steroidal therapy in experimental corneal injury. Ophthalmic Res 1997;29:145-153.
4. Bankova V, Dyulgerov A, Popov S, Evstattieva L, Kuleva L, Pureb O, Zamjansan Z: Propolis produced in Bulgaria and Mongolia: Phenolic compounds and plant origin. Apidologie 1992; 23:79-85.
5. Garcia-Viguera C, Ferreres F, Tomas-Barberab FA: Study of Canadian propolis by GC-MS and HPLC. Z Naturforsch 1993;48:731-735.
6. Greenaway W, Scaysbrook T, Whatley FR: The analysis of bud exudate of populus X euramericana, and of propolis, by gas chromatographymass spectrometry. Proc R Soc Lond B 1987; 232:249-272.
7. Walker P, Crane E: Constituents of propolis. Apidologie 1987;18:327-334.
8. Scheller S, Krol W, Swiacik J, Owczarek S, Gabrys J, Shani J: Antitumoral property of ethanolic extract of propolis in mice bearing Ehrlich carcinoma, as compared to bleomycin. Z Naturforsch 1989;44:1063-1065.
9. Ivanov DF, Tikanov AI, Krivenohuk PE, Liurskaia FV: Propolis and its clinical usage. Ophthalmol Zh 1973;28:104-107.
10. Alio JL, Ayala MJ, Mulet ME, Artola A, Ruiz JM, Bellot J: Antioxidant therapy in the treatment of experimental acute corneal inflammation. Ophthalmic Res 1995;27:136-143.
11. Ormerod LD, Abelson MB, Kenton KR: Standard models of corneal injury using alkali-immersed filter discs. Invest Ophthalmol Vis Sci 1989;30:2148-2153.
12. Fromer CH, Klintworth GK: An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. I. Comparison of experimental models of corneal vascularization. Am J Pathol 1975;79: 537-554.
13. Paterson CA, Williams, RN, Parker AV: Characteristics of PMN infiltration into the alkali burned eye and the influence of sodium citrate. Exp Eye Res 1984;39:701-708.
14. Brown SI, Weller CA: The pathogenesis and treatment of collagen-induced disease of the cornea. Trans Am Acad Ophthalmol Otolaryngol 1970;74:375-383.
15. Perry HD, Hodes LW, Seedor JA, Donnenfeld ED, McNemara TF, Golub LM: Effect of doxycycline hyclate on corneal epithelial wound healing in the rabbit alkali-burn model. Cornea 1993;12:379-382.
16. Conners MS, Urbano F, Vafeas C, Stoltz RA, Dunn MW, Schwartzman ML: Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium. Invest Ophthalmol Vis Sci 1997;38:1963-1971.
17. Davis AR, Ali QH, Aclimandos WA, Hunter PA: Topical steroid use in the treatment of ocular alkali burns. Br J Ophthalmol 1997;81:732-734.
18. Struck HG, Franke C, Tost M, Taube C: Animal experiment and clinical studies on the use of anti-inflammatory agents in chemical burns of the eye. Klin Monatsbl Augenheilkd 1988; 193:401-406.
19. Dobrowolski JW, Vohoraq SB, Sharma K, Shah SA, Naqvi SAH, Dandiya PC: Antibacterial, antifungal, antiamocbic, anti-inflammatory, and antipyretic studies on propolis bee products. J Ethnopharmacol 1991;35:77-82.
20. Khayyal MT, el-Ghazaly MA, el-Khatip AS: Mechanisms involved in the anti-inflammatory effect of propolis extract. Drugs Exp Clin Res 1993;19:197-203.
21. Strehl E, Volpert R, Elstner EF: Biochemical activities of propolis extracts. III. Inhibition of dehydrofolate reductase. Z Naturforsch 1994; 48:39-43.
22. Volpert R, Elstner EF: Interactions of different extracts of propolis with leukocytes and leukocytic enzymes. Arzneimittelforschung 1996;46: 47-51.
23. Mirzoeva OK, Calder PC: The effect of propolis and its components on eicosanoid production during the inflammatory response. Prostaglandins Leucot Essent Fatty Acids 1996;55: 441-449.
24. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD: Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993;329:21-24.
25. Carubelli R, Norquist R, Rowsey J: Role of active oxygen species in corneal ulceration. Cornea 1990;9:161-169.
26. Fantone J, Ward P: Role of oxygen derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982;107:397-418.
27. Nirankari VS, Varma SD, Lakhanpal V, Richards RD: Superoxide radical scavenging agents in treatment of alkali burns. Arch Opthalmol 1981;99:886-887.
28. Krol W, Czuba Z, Scheller S, Gabrys J, Grabiec S, Shani J: Anti-oxidant property of ethanolic extract of propolis (EEP) evaluated by inhibiting the chemiluminescence oxidation of luminol. Biochem Int 1990;21:593-597.
29. Pascual C, Gonzalez R, Torricella RG: Scavenging action of propolis extract against oxygen radicals. J Ethnopharmacol 1994;41:9-13.
30. Grunberger D, Banerjee R, Eisinger K, Oltz EM, Efros L, Caldwell M, Estevez V, Nakanishi K: Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988;44:230-232.